Ovarian function after autologous bone marrow transplantation in childhood: High-dose busulfan is a major cause of ovarian failure

Bone Marrow Transplantation

Volumn 22, Issue 10, 1998, Pages 989-994

  Teinturier, C ^a   Hartmann, O ^b   Valteau Couanet, D ^b   Benhamou, E ^b   Bougneres, P F ^a  

^a HÔPITAL SAINT VINCENT DE PAUL   (France)

^b INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Bone marrow transplantation; Busulfan; Childhood; High dose chemotherapy; Ovarian function

Indexed keywords

ALKANESULFONIC ACID DERIVATIVE; BUSULFAN; CYCLOPHOSPHAMIDE; GONADOTROPIN; MELPHALAN;

ADOLESCENT; ADULT; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CLINICAL ARTICLE; DRUG MEGADOSE; ESTROGEN THERAPY; FEMALE; FOLLOW UP; GONADOTROPIN BLOOD LEVEL; HUMAN; OVARY FUNCTION; OVARY INSUFFICIENCY; PRIORITY JOURNAL; PUBERTY; SCHOOL CHILD;

EID: 0031722549     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701483     Document Type: Article

References (39)

1. Sanders J, Pritchard S, Mahoney P et al. Growth and development following marrow transplantation for leukemia. Blood 1986; 70: 324-326.
2. Sanders J, Buckner CD, Amos D et al. Ovarian function following marrow transplantation for aplastic anemia or leukemia. J Clin Oncol 1988; 6: 813-818.
3. Liesner R, Leiper A, Hann I et al. Late effects of intensive treatment for acute myeloid leukemia and myelodysplasia in childhood. J Clin Oncol 1994; 12: 916-924.
4. Leiper AD, Stanhope R, Lau T et al. The effect of total body irradiation and bone marrow transplantation during childhood and adolescence on growth and endocrine function. Br J Haematol 1987; 67: 419-426.
5. Clark ST, Radford JA, Crowther D et al. Gonadal function following chemotherapy for Hodgkin's disease: a comparative study of MVPP and a seven-drug hybrid regimen. J Clin Oncol 1995; 13: 134-139.
6. Chapman RM, Sutcliffe SB, Rees LH et al. Cyclical combination chemotherapy and gonadal function. Lancet 1979; 1: 285-289.
7. Horning S, Hoppe R, Kaplan H et al. Female reproductive potential after treatment for Hodgkin's disease. New Engl J Med 1981; 304: 1377-1382.
8. Senker G, Schafer U, Hermanns U et al. Allogenic bone marrow transplantation in adults: endocrine sequelae after 1-6 years. Acta Endocrinol 1989; 120: 37-42.
9. Sklar CA, Kim TH, Williamson F, Ramsay NKC. Ovarian function after successful bone marrow transplantation in post- menarcheal females. Med Pediatr Oncol 1983; 11: 361-364.
10. Tanner JM. Growth at Adolescence, 2nd edn. Blackwell: Oxford, 1966, p 32.
11. Nicosia SV, Matus-Ridley M, Meadows AT. Gonadal effects of cancer therapy in girls. Cancer 1985; 55: 2364-2372.
12. Wallace W, Shalet SM, Tetlow LJ, Morris-Jones PH. Ovarian function following the treatment of childhood acute lymphoblastic leukaemia. Med Pediatr Oncol 1993; 21: 333-339.
13. Hamre MR, Robison LL, Nesbit ME et al. Effects of radiation on ovarian function in long-term survivors of childhood acute lymphoblastic leukaemia: a report from the childrens cancer study group. J Clin Oncol 1987; 5: 1759-1765.
14. Quigley C, Cowell C, Jimenez M et al. Normal or early development of puberty despite gonadal damage in children treated for acute lymphoblastic leukemia. New Engl J Med 1989; 321: 143-151.
15. Keilholz U, Korbling M, Fehrentz D et al. Long-term endocrine toxicity of myeloablative treatment followed by autologous bone marrow/blood derived stem cell transplantation in patients with malignant lymphohematopoictic disorders. Cancer 1989; 64: 641-645.
16. Viviani S, Santoro A, Ragni G et al. Gonadal toxicity after combination chemotherapy for Hodgkin's disease. Comparative results of MOPP vs ABVD. Eur J Cancer Clin Oncol 1985; 21: 601-605.
17. Canellos G, Anderson JR, Propert KJ et al. Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD or MOPP alternating with ABVD. New Engl J Med 1992; 327: 1478- 1484.
18. Byrne J, Fears TR, Gail MH et al. Early menopause in long term survivors of cancer during adolescence. Am J Obstet Gynecol 1992; 166: 788-793.
19. Livesey EA, Brook CGD. Gonadal dysfunction after treatment of intracranial tumours. Arch Dis Child 1988; 63: 495-500.
20. Clayton PE, Shalet SM, Price DA, Morris-Jones PH. Ovarian function following chemotherapy for childhood brain tumors. Med Pediatr Oncol 1989; 17: 92-96.
21. Ahmed SR, Shalel SM, Campbell RHA et al. Primary gonadal damage following treatment of brain tumors in childhood. J Pediatr 1983; 103: 562-565.
22. Shalet SM. Effects of cancer chemotherapy on gonadal function of patients. Cancer Treat Rev 1980; 7: 141-152.
23. Cohen A, Van Lint MT, Lavagetto A et al. Pubertal development and fertility in children after bone marrow transplantation. Bone Marrow Transplant 1991; 8 (Suppl. 1): 16-20.
24. Heimpel H, Arnold R, Hetzel WD et al. Gonadal function after bone marrow transplantation in adult male and female patients. Bone Marrow Transplant 1991; 8 (Suppl. 1): 21-24.
25. Samuelsson A, Fuchs T, Simonsson B, Björkholm M. Successful pregnancy in a 28-year-old patient autografted for acute lymphoblastic leukemia following myeloablative treatment including total body irradiation. Bone Marrow Transplant 1993; 12: 659-660.
26. Sarafoglou K, Boulad F, Gillio A, Sklar C. Gonadal function after bone marrow transplantation for acute leukemia during childhood. J Pediatr 1997; 130: 210-216.
27. Al Chalabi HA. Effect of cyclosporin A on the morphology and function of the ovary and fertility in the rabbit. Int J Fertil 1984; 29: 218-223.
28. De Sanctis V, Galimberti M, Lucarelli G et al. Gonadal function after allogenic bone marrow transplantation for thalassaemia. Arch Dis Child 1991; 66: 517-520.
29. Sanders JE. Endocrine problems in children after bone marrow transplant for hematologic malignancies. Bone Marrow Transplant 1991; 8 (Suppl. 1): 2-4.
30. Giorgiani G, Bozzola M, Cisternino M et al. Gonadal function in adolescents receiving different conditioning regimens for bone marrow transplantation. Bone Marrow Transplant 1991; 8 (Suppl. 1): 53.
31. Sanders J, Hawley J, Levy W et al. Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation. Blood 1996; 87: 3045-3052.
32. Lopez-Ibor B, Schwartz AD. Gonadal failure following busulfan therapy in an adolescent girl. Am J Pediatr Hematol Oncol 1986; 8: 85-87.
33. Michel G, Socié G, Gebhard F et al. Late effects of allogeneic bone marrow transplantation for children with acute myeloblastic leukemia in first complete remission: the impact of conditioning regimen without total body irradiation. A report from the Société Française de greffe de moelle. J Clin Oncol 1997; 15: 2238-2246.
34. Thibaud E, Rodriguez-Macias K, Trivin C et al. Ovarian function after bone marrow transplantation during childhood. Bone Marrow Transplant 1998; 21: 287-290.
35. Salooja N, Chatterjee R, McMillan AK et al. Successful pregnancies in women following single autotransplant for acute myeloid leukemia with a chemotherapy ablation protocol. Bone Marrow Transplant 1994; 13: 431-435.
36. Giri N, Vowels MR. Barr AL, Mameghan H. Successful pregnancy after total body irradiation and bone marrow transplantation for acute leukemia. Bone Marrow Transplant 1992; 10: 93-95.
37. Ataya KM, McKanna JA, Weintraub et al. A prevention of chemotherapy-induced ovarian follicular loss in rats. Cancer Res 1985; 45: 3651-3656.
38. Ataya KM, Rao LW, Laurence E, Kimmel R. Luteinizing hormone-releasing hormone agonist inhibits cyclophosphamide induced ovarian follicular depletion in rhesus monkeys. Biol Reprod 1995; 52: 365-372.
39. Blumenfeld Z, Haim N. Prevention of gonadal damage during cytotoxic therapy. Ann Med 1997; 29: 199-206.